Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative review.
Authors: Kaltseis et al.
Posted in Papers / Review /Â November 16-30, 2022
Headache. 2022 Nov 27. Online ahead of print.
PMID: 36437611 | DOI: 10.1111/head.14415
Share this article
Sign Up For An MSC Newsletter
Sign Up for MSC Content Alerts!
Interested in receiving notifications about new MSC content? Then sign up for our content alerts and be the first to know about our latest articles, literature recaps and more!